Atrial fibrillation is a major cause of ischemic stroke, but is aspirin a major help for stroke prevention or not?

Aspirin in Stroke Prevention in Nonvalvular Atrial Fibrillation and Stable Vascular Disease An Era of New Anticoagulants Mohit K Turagam; Poonam Velagapudi; Miguel A Leal; Abraham G Kocheril ...

Nonvalvular AF (NVAF) is associated with a 5-fold increase in risk of ischemic stroke and accounts for 15% to 20% of all strokes. 2 Healthcare utilization associated with AF is substantial due, at ...

Discussion In this large cohort of patients with nonvalvular AF, we assessed the real‐world effectiveness and safety of dabigatran, rivaroxaban, and apixaban, comparing each agent with warfarin.

Objectives This study evaluated the comparative effectiveness of vitamin K antagonists (VKAs), direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaI) in patients with atrial fibrillation ...

Objectives To evaluate the association between left atrial appendage volume (LAAV) and atrial fibrillation (AF) recurrence after catheter ablation (CA) and explore the potential mechanism. Design ...

Since their initial approval in 2010, DOACs such as dabigatran (thrombin inhibitor - factor IIa, FIIa), apixaban, edoxaban, and rivaroxaban (inhibitors of factor Xa, FXa) have gained widespread usage ...

Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants.

Atrial fibrillation (AF) is characterised by an increased risk of pathological thrombus formation due to a disruption of physiological haemostatic mechanisms that are better understood by reference to ...

Objective Patients with Fontan surgery experience late complications in adulthood. We studied the factors associated with the development and maintenance of atrial arrhythmias and thromboembolic ...